Disclosures for "Regional Cortical Demyelination Predicts Word-Finding Difficulty in Early Multiple Sclerosis"
-
Ms. Cheshire has nothing to disclose.
-
Ms. Dereskewicz has nothing to disclose.
-
Mr. Ayci has nothing to disclose.
-
Mr. Dos Santos Silva has nothing to disclose.
-
Miss Feng has nothing to disclose.
-
Ms. Galasso has nothing to disclose.
-
Dr. La Rosa has nothing to disclose.
-
Mr. Sumowski has nothing to disclose.
-
Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Glaxo Smith Kline. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharmaceutical Corporation. An immediate family member of Dr. Beck has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Swedish Orphan Biovitrum AB. The institution of Dr. Beck has received research support from National Multiple Sclerosis Society. The institution of Dr. Beck has received research support from National Institutes of Health. The institution of Dr. Beck has received research support from United States Department of Defense. The institution of Dr. Beck has received research support from Consortium of Multiple Sclerosis Centers. Dr. Beck has received intellectual property interests from a discovery or technology relating to health care.